KEY FINDINGS
The India clinical trial management market is estimated to project a CAGR of 15.57% during the forecast period, 2021-2026. The increasing disease burden, reduced approval period, high population, and online registry contribute to market growth.
MARKET INSIGHTS
The digitalization of clinical trials is expected to drive market growth in India. It has facilitated the streamlining of many clinical trial processes like logistics and supplies management, regulatory compliance, data capture, etc. The launch of digital therapeutics and the ease of real-time data acquisition related to safety & toxicity enables timely rectification in trial design, thereby promoting the market growth.
Furthermore, a significant percentage of the Indian population does not have access to advanced treatment and medicines, given the financial and geographic barriers. As per the Institute for Studies in Industrial Development Report, the country ranks second with regard to patient population for clinical trials. Also, the clinical trials are half-priced from that of Europe and the US. Moreover, the country is also emerging as a top destination for contract research organizations, given its acceptance of international intellectual property rights and guidelines, accessible human resources, low operational costs, availability of a large patient pool, and diverse climatic conditions. Such factors are predicted to influence the growth of the India clinical trial management market.
COMPETITIVE INSIGHTS
Some of the prominent companies in the market are Parexel International Corporation, Oracle Corporation, ArisIndia LLC, Veeva Systems Inc, Medidata Solutions Inc, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments